Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net income (loss) $ 6,526 $ (95,052)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 97,919 88,418
Stock-based compensation expense 12,960 7,078
Deferred tax provision (benefit) 967 (11,986)
Gain on sale of assets, net (641) (229)
Gain on sale of ownership interest in a subsidiary 0 (11,208)
Unrealized gain on investments (1,336) (1,161)
Loss from equity-method investments 0 3,542
Goodwill write-down 0 90,408
Changes in working capital items (7,513) 41,726
Decrease in other assets 2,632 5,076
(Decrease) increase in other liabilities (6,064) 2,960
Other operating activities, net 1,407 4,036
Net cash provided by operating activities 106,857 123,608
Cash flows from investing activities:    
Capital expenditures (24,495) (25,486)
Acquisitions, net of cash acquired (15,623) 0
Proceeds from sale of assets 2,211 398
Proceeds from sale of investments 15,000 0
Proceeds from sale of ownership interest in subsidiary 0 42,210
Investments and advances 0 (9,723)
Net cash (used in) provided by investing activities (22,907) 7,399
Cash flows from financing activities:    
Proceeds from long-term debt 385,065 971,399
Payments on long-term debt (434,089) (1,063,459)
Purchases of treasury stock (6,149) (2,372)
Dividends (20,856) (19,813)
Acquisition holdback and contingent consideration payments (1,556) (4,689)
Other financing activities (2,245) (4,156)
Net cash used in financing activities (79,830) (123,090)
Effect of exchange rate changes on cash 776 (315)
Net change in cash and cash equivalents 4,896 7,602
Cash and cash equivalents at beginning of year 41,334 35,302
Cash and cash equivalents at end of period $ 46,230 $ 42,904